Results 211 to 220 of about 106,790 (296)

The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment. [PDF]

open access: yesEur Psychiatry
Zeng J   +17 more
europepmc   +1 more source

Validation of a transdiagnostic measure of fears of recurrence and progression about mental health conditions

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Objectives Fears of recurrence and progression (FORP) in people with mental health conditions are understudied despite predicting poorer psychological outcomes and increased rates of relapse. However, there are no well‐validated questionnaires that assess FORP in people with non‐psychotic conditions.
Daelin Coutts‐Bain   +2 more
wiley   +1 more source

Understanding excessive sleep in people with psychotic disorders

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Background There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible ...
Kate Robbins   +2 more
wiley   +1 more source

Understanding the relationships between parenting, attachment, schemas and psychosis: A serial mediation analysis

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Background Parenting experiences during childhood have been suggested to inform the development of an individual's attachment style and core schemas. Additionally, parenting, attachment and schemas have all individually been linked to symptoms of psychosis in adulthood.
Nadia Akers   +2 more
wiley   +1 more source

Antipsychotic prescribing patterns by dermatologists in the Medicare population. [PDF]

open access: yesJAAD Int
Ahmad AS   +5 more
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

open access: yesBritish Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy